The NYT has an article reporting on how test results on Zetia, a new cholesterol lowering drug, were hidden or misrepresented. It never mentions the incentives given by patent protection for this sort of corruption. There are alternatives to patent protection for financing drug research. It is remarkable that this never gets mentioned in news reporting. The distortions created by patent protection for prescription drugs dwarf the distortions created by the protectionist measures that "free traders" focus their sights on.
--Dean Baker